previous recipients
Annual Awards '17 << Back

  1. The Pharmaceutical Society of Japan Award '17
    • Takeo Kawabata (Institute for Chemical Research, Kyoto University, Professor)
      Novel Strategies for Enantio- and Site-Selective Molecular Transformations
    • Kazuki Saito (Graduate School of Pharmaceutical Sciences, Chiba University / RIKEN Center for Sustainable Resource Science, Dean, Professor / Deputy Center Director)
      Development of plant metabolomics and medicinal plant genomics
    • Shigeki Sasaki (Graduate School of Pharmaceutical Sciences, Kyushu University, Professor)
      Development of the novel functional molecules targeting DNA and RNA
    • Hideo Saji (Graduate School of Pharmaceutical Sciences, Kyoto University, Professor)
      In vivo Molecular Imaging

  2. The Pharmaceutical Society of Japan Award for Divisional Scientific Contribution '17
    • Masaaki Kurihara (National Institute of Health Sciences, Head of Division)
      Design and Functionalization of Molecules towards Drug Discovery
    • Hidetoshi Arakawa (Showa University, School of Pharmacy,Professor)
      Development of highly sensitive analytical method for biologically relevant materials and its pharmaceutical applications.
    • Takashi Suzuki (Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Professor)
      Imaging of sialidase activity and detection of cancer cells and viruses

  3. The Pharmaceutical Society of Japan Award for Divisional Scientific Promotion '17
    • Mitsuhiro Arisawa (Osaka University, Graduate School of Pharmaceutical Sciences, Associate Professor)
      Development of Highly Efficient Metal Nano-particle Catalyst toward Drug Discovery
    • Yaichiro Kotake (Hiroshima University, Associate Professor)
      Neurotoxicity mechanism of environmental chemicals and its evaluation system

  4. The Pharmaceutical Society of Japan Award for Young Scientists '17
    • Hideyuki Konishi (School of Pharmaceutical Sciences, University of Shizuoka, Research Assistant Professor)
      Creation of novel toxic gas surrogates and development of safe and facile catalytic reactions
    • Toru Komatsu (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Assistant Professor)
      Development of chemical biological tools to characterize disease-related enzymatic functions
    • Hiroki Shigehisa (Musashino University, Faculty of Pharmaceutical Sciences, Lecturer)
      Studies on catalytic activation of olefins using cobalt complex
    • Jun Shimokawa (Graduate School of Pharmaceutical Sciences, Nagoya University, Assistant Professor)
      Studies on Divergent Syntheses of Natural Products
    • Toshihide Takeuchi (Osaka University Graduate School of Medicine, Endowed Chair Associate Professor)
      Toward understanding mechanisms underlying non-cell autonomous regulation of cellular functions
    • Kazuya Nagano (Graduate School of Pharmaceutical Sciences, Osaka University, Associate Professor)
      Development and evaluation of an efficient fundamental technology to identify biomarkers and drug targets
    • Hiroto Hatakeyama (Chiba University, Faculty of Pharmaceutical Sciences, Assistant Professor)
      Development of a novel liposomal DDS by manipulating pharmacokinetics and intracellular trafficking for drug therapy and nucleic acid medicine
    • Taniyuki Furuyama (Graduate School of Natural Science and Technology, Kanazawa University, Associate Professor)
      Design and Synthesis of Functional π Molecules and Their Application to Near-IR Materials

  5. The Pharmaceutical Society of Japan Award for Drug Research and Development '17
    • Research and Development of HIV-1 Integrase Inhibitor, Dolutegravir
      Tomokazu Yoshinaga (Head of Antiviral 1, Infectious Diseases,Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd.)
      Tamio Fujiwara (HIV Integrase Inhibitor Global Project Leader, Global Development, Shionogi & Co., Ltd.)
      Takashi Kawasuji (Head of Chemistry Infectious Diseases, Medicinal Chemistry Research Laboratory, Shionogi & Co., Ltd.)
      Brian A. Johns (VP and Head, HIV Discovery Performance Unit, Infectious Diseases R&D, GlaxoSmithKline )
      Akihiko Sato (Team Leader, Emerging Infectious Diseases, Drug Discovery & Disease Research Laboratory Shionogi & Co. Ltd.)
    • Discovery of alectinib, a selective ALK (anaplastic lymphoma kinase) inhibitor
      Nobuhiro Oikawa (Chugai Pharmaceutical Co., Ltd. Medicinal Chemistry Research Dept. Senior Specialist)
      Hiroshi Sakamoto (Chugai Pharmaceutical Co., Ltd. Safety Assessment Dept. Group Manager.)
      Kenji Takanashi (Chugai Pharmaceutical Co., Ltd. Pre-Clinical Research Dept. Researcher)
      Hiromi Suzuki (Chugai Pharmaceutical Co., Ltd. Safety Assessment Dept. Group Manager.)
      Yasushi Yoshimura (Chugai Pharmaceutical Co., Ltd. Product Research Dept. Chugai Pharmaceutical Co. Ltd., Scientist)

  6. The Pharmaceutical Society of Japan Award for Distinguished Service '17
    • Toshio Fujita (Emeritus Professor, Kyoto University)

  7. The 40 th Sato Memorial Fund
    • Naomi Kurata (Division of Community Healthcare and Pharmacy, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, professor)
      The development and dissemination of the Simple Suspension Method

<< Back